subject: Double Heron Pharmaceutical: Anti [print this page] As another new drug, "818 Project", the company said the drug will enjoy a 25% interest in overseas markets. The market prospect is the treatment of male infertility innovative international patent medicines, and treatment with the company's current R & D form a series of infertility drugs. Clinical trial is expected to require 3 years to 4 years.
